FindTrial
Sign In

Role of Homoeopathy in Management of Rheumatoid arthritis

Efficacy of individualized homoeopathic intervention versus specific homoeopathic intervention using Guaiacum officinale in centesimal scale in reducing rheumatoid factor levels in patients of rheumatoid arthritis: A single-blind randomized controlled trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094672
Enrollment
60
Registered
2025-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicines will be Prescribed Based on Detailed Case taking, Symptom Totality Formation, and Repertorization using appro

Sponsors

Nehru Homoeopathic Medical College And Hospital , Defence Colony B block ,New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18?65 years. 2.Cases of Both sexes. 3.Diagnosed with RA as per 2010 ACR or EULAR criteria. 4.Positive Rheumatoid Factor at baseline. 5.Disease duration more than 6 weeks. 6.Patient willing to participate voluntarily and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with other severe systemic illnesses, malignant disorders, autoimmune diseases or any organic disease. 2.Patients on long-term corticosteroids or immunosuppressants. Any major surgery in the last 6 months. 3.Patients under other medication from past 2-3 months for the same complaint. 4.Unexplained weight loss. 5.RA with severe joint deformities or contractures. 6.Patients with cognitive impairment. 7.Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Rheumatoid Factor levelsTimepoint: Rheumatoid Factor levels will be evaluated at baseline and at 12 weeks interval—

Secondary

MeasureTime frame
Disease Activity Score 28 (DAS 28)Timepoint: DAS 28 Score will be evaluated at baseline and at 12 weeks interval—

Countries

India

Contacts

Public ContactDr Abhishek Kumar singh

Nehru Homoeopathic Medical College And Hospital

drmohitmathur@gmail.com9818449588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026